Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James M Karis Insider Profile
4 Followers
James M Karis, Director at Shield Therapeutics, holds 161.67K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, James M Karis Bought 75,000p shares of Shield Therapeutics on Aug 15, 2019 for an estimated value of 133.50K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-29.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that James M Karis holds in companies
Most Profitable Insider Trade
The most profitable trade made by James M Karis
James M Karis's Trading History
List of latest transactions for each holding click on a transaction to see James M Karis's performance on stock
You May Also Like
James M Karis insider profile FAQ
What is the percentage of profitable transactions made by James M Karis?
The percentage of profitable transactions made by James M Karis is 33%.
What is the average return per transaction made by James M Karis?
The average return per transaction made by James M Karis is -29.40%.
What stocks does James M Karis hold?
James M Karis holds: GB:STX stocks.
What was James M Karis’s latest transaction?
James M Karis latest transaction was an Informative Buy of 133.50K.
What was James M Karis's most profitable transaction?
James M Karis’s most profitable transaction was an Informative Buy of GB:STX stock on April 17, 2019. The return on the trade was 15.40%.
What is James M Karis's role in Shield Therapeutics?
James M Karis's role in Shield Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.